Eiger BioPharmaceuticals, Inc. (EIGRQ)
USD 8.5
(6.25%)
USD 8.5
(6.25%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -71.03 Million USD | 22.7% |
| 2022 | -91.89 Million USD | -20.7% |
| 2021 | -76.14 Million USD | -23.8% |
| 2020 | -61.5 Million USD | 10.11% |
| 2019 | -68.41 Million USD | -34.17% |
| 2018 | -50.99 Million USD | -22.94% |
| 2017 | -41.47 Million USD | 10.02% |
| 2016 | -46.09 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q1 | -22.07 Million USD | 8.99% |
| 2023 Q4 | -12.43 Million USD | 25.68% |
| 2023 FY | - USD | 22.7% |
| 2023 Q2 | -19.79 Million USD | 10.31% |
| 2023 Q3 | -16.73 Million USD | 15.5% |
| 2022 Q3 | -26.15 Million USD | -31.63% |
| 2022 Q1 | -21.61 Million USD | -4.33% |
| 2022 FY | - USD | -20.7% |
| 2022 Q4 | -24.25 Million USD | 7.27% |
| 2022 Q2 | -19.87 Million USD | 8.07% |
| 2021 Q4 | -20.71 Million USD | 4.34% |
| 2021 FY | - USD | -23.8% |
| 2021 Q3 | -21.65 Million USD | -19.34% |
| 2021 Q2 | -18.14 Million USD | 0.0% |
| 2020 FY | - USD | 10.11% |
| 2019 FY | - USD | -34.17% |
| 2018 FY | - USD | -22.94% |
| 2017 FY | - USD | 10.02% |
| 2016 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | -1098.129% |
| SQZ Biotechnologies Company | -64.14 Million USD | -10.75% |
| Evofem Biosciences, Inc. | -17.37 Million USD | -308.958% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 175.54% |
| Mesoblast Limited | -62.38 Million USD | -13.858% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -4524.592% |
| Genus plc | 73.7 Million USD | 196.385% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | -974.428% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | -1902.708% |
| Marizyme, Inc. | -34.28 Million USD | -107.214% |
| ContraFect Corporation | -64.99 Million USD | -9.288% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | -709.804% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | -1469.442% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -4967.456% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | -2586.232% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | -2956.863% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -13612.296% |
| Accustem Sciences Inc. | -3.74 Million USD | -1796.104% |
| RVL Pharmaceuticals plc | -48.22 Million USD | -47.295% |
| EV Biologics, Inc. | -1.26 Million USD | -5506.046% |
| Q BioMed Inc. | -617.62 Thousand USD | -11401.422% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 2088.69% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -11132.658% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | -3009.492% |
| Biomind Labs Inc. | -1.03 Million USD | -6766.374% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 819.206% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | -891.946% |
| Skye Bioscience, Inc. | -13.54 Million USD | -424.346% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -4675.812% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -284044.0% |
| Arch Therapeutics, Inc. | -3.88 Million USD | -1728.789% |
| IMV Inc. | -35.52 Million USD | -99.97% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -347.619% |
| Curative Biotechnology, Inc. | -2.5 Million USD | -2739.212% |
| GB Sciences, Inc. | -1.41 Million USD | -4902.94% |
| Alpha Cognition Inc. | -9.7 Million USD | -631.907% |
| HST Global, Inc. | -5303.00 USD | -1339443.655% |
| CSL Limited | 4.78 Billion USD | 101.483% |
| Halberd Corporation | -74.27 Thousand USD | -95534.028% |
| Enzolytics Inc. | -2.12 Million USD | -3247.551% |
| Resverlogix Corp. | -11.74 Million USD | -504.974% |
| Affymax, Inc. | -14.29 Million USD | -396.929% |
| SYBLEU INC | -141.57 Thousand USD | -50076.943% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | -2219.152% |
| argenx SE | -216.02 Million USD | 67.116% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | -28.365% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 5936.976% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -4639.19% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 18850.726% |
| AVAX Technologies, Inc. | -6.11 Million USD | -1062.116% |
| Zenith Capital Corp. | -8.6 Million USD | -725.424% |
| Genscript Biotech Corporation | -248.71 Million USD | 71.439% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -407660.749% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | -2803.623% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -40255.778% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | -79.217% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | -2356.016% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | -6689.18% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 1056554.491% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -3959.202% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -3598.037% |
| BioStem Technologies, Inc. | -7.55 Million USD | -840.42% |
| ONE Bio Corp. | 13.61 Million USD | 621.823% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -39127.337% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -3353.379% |
| Agentix Corp. | -1.37 Million USD | -5078.472% |
| LadRx Corporation | 412.28 Thousand USD | 17329.912% |
| Cell Source, Inc. | -4.27 Million USD | -1562.623% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -19244.21% |
| Regen BioPharma, Inc. | 1.46 Million USD | 4945.712% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -7481.629% |
| NovAccess Global Inc. | -1.03 Million USD | -6764.728% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 902.322% |
| Itoco Inc. | -1.86 Million USD | -3700.759% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -18612.397% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -6265.233% |
| Kadimastem Ltd | -2.62 Million USD | -2606.772% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -29603.533% |
| CytoDyn Inc. | -18.02 Million USD | -294.01% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -89785.991% |
| Mobile Lads Corp. | -2.24 Million USD | -3069.61% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -580781.511% |
| Qrons Inc. | -40.08 Thousand USD | -177131.107% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -14526.151% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 13568.251% |
| Rebus Holdings, Inc. | -951 Thousand USD | -7369.611% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -6588.826% |
| International Stem Cell Corporation | 202 Thousand USD | 35266.337% |
| Bioxytran, Inc. | -3.82 Million USD | -1759.51% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -134846.809% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | -2785.376% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | -98.043% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -157757.778% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | -2494.449% |
| Neutra Corp. | -181.24 Thousand USD | -39092.925% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -252.379% |
| PureTech Health plc | -11.62 Million USD | -510.957% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | -252.403% |
| IXICO plc | -707 Thousand USD | -9947.525% |
| IntelGenx Technologies Corp. | -7.68 Million USD | -824.346% |
| Gelesis Holdings, Inc. | -48.34 Million USD | -46.933% |
| CSL Limited | 4.73 Billion USD | 101.501% |
| Cellectis S.A. | -92.63 Million USD | 23.317% |